Title

Management of Giant Cell Arteritis and Takayasu Arteritis

Authoring Organization

American College of Rheumatology

Publication Month/Year

July 7, 2021

Last Updated Month/Year

December 13, 2024

Document Type

Guideline

External Publication Status

Published

Country of Publication

US

Document Objectives

To provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis.

Target Patient Population

Patients with giant cell arteritis (GCA) and Takayasu arteritis (TAK)

Inclusion Criteria

Male, Female, Adolescent, Adult, Child, Older adult

Health Care Settings

Ambulatory

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Diagnosis, Assessment and screening, Treatment, Management

Diseases/Conditions (MeSH)

D056653 - Rheumatoid Vasculitis, D014657 - Vasculitis, D013700 - Giant Cell Arteritis, D013625 - Takayasu Arteritis

Keywords

vasculitis, GCA, giant cell arteritis, Takayasu arteritis

Source Citation

Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis & Rheumatology, Vol. 73, No. 8, August 2021, pp 1349–1365. doi 10.1002/art.41774